Dexcom, Inc. (DXCM) fundamentals score
Dexcom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 8.8 out of 10, Strong long-term fundamentals
- Growth: 6.7/10
- Profitability: 9.5/10
- Financial health: 9.8/10
- Earnings quality: 9.5/10
- Valuation: 8.9/10
Scores are calculated from Dexcom, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10
- Globus Medical, Inc. (GMED): 8.4/10